PAFSC’s First Committee to Review Second SGLT-2 Inhibitor Dapagliflozin on Jan 24

January 15, 2014
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory body to the health minister, will discuss on January 24 whether to support approval of Bristol Myers’s dapagliflozin for the treatment of diabetes. If approved, dapagliflozin...read more